On November 2, 2021 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, reported that company management will participate in the following upcoming investor conferences (Press release, Xencor, NOV 2, 2021, View Source [SID1234595189]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Credit Suisse 30th Annual Healthcare Conference
Presentation: Tuesday, November 9, 2:40 p.m. ET / 11:40 a.m. PT
Jefferies London Healthcare Conference
Presentation on-demand availability: Thursday, November 18, 8:00 a.m. GMT / 12:00 a.m. PT
Webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. Replays will be archived on the website for at least 30 days.